Myocardial contractile force in hemorrhagic shock. Treatment with phenoxybenzamine hydrochloride, metaproterenol sulfate, or these agents combined.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D004285:Dogs; D006321:Heart / Q000187:drug effects / Q000503:physiopathology*; D006863:Hydrogen-Ion Concentration; D009921:Metaproterenol / Q000494:pharmacology / Q000627:therapeutic use; D009119:Muscle Contraction / Q000187:drug effects; D010643:Phenoxybenzamine / Q000494:pharmacology / Q000627:therapeutic use*; D012771:Shock, Hemorrhagic / Q000188:drug therapy / Q000503:physiopathology*; D014554:Urination / Q000187:drug effects
D001993:Bronchodilator Agents; D010643:Phenoxybenzamine; D009921:Metaproterenol